LT4069232T - Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui - Google Patents

Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui

Info

Publication number
LT4069232T
LT4069232T LTEPPCT/IB2020/061383T LTIB2020061383T LT4069232T LT 4069232 T LT4069232 T LT 4069232T LT IB2020061383 T LTIB2020061383 T LT IB2020061383T LT 4069232 T LT4069232 T LT 4069232T
Authority
LT
Lithuania
Prior art keywords
masupirdine
dementia
psychological symptoms
treating behavioral
behavioral
Prior art date
Application number
LTEPPCT/IB2020/061383T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Pradeep Jayarajan
Satish JETTA
Raghava Chowdary PALACHARLA
Santosh Kumar Pandey
Abdul Rasheed Mohammed
Vijay Sidram BENADE
Vinod Kumar GOYAL
Ramkumar Subramanian
Jyothsna Ravula
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Limited filed Critical Suven Life Sciences Limited
Publication of LT4069232T publication Critical patent/LT4069232T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEPPCT/IB2020/061383T 2019-12-02 2020-12-02 Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui LT4069232T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201941049517 2019-12-02
IN201941049516 2019-12-02
PCT/IB2020/061383 WO2021111330A1 (en) 2019-12-02 2020-12-02 Treating behavioral and psychological symptoms in dementia patients

Publications (1)

Publication Number Publication Date
LT4069232T true LT4069232T (lt) 2026-02-10

Family

ID=74003821

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/IB2020/061383T LT4069232T (lt) 2019-12-02 2020-12-02 Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui

Country Status (21)

Country Link
US (1) US20220409614A1 (lt)
EP (1) EP4069232B1 (lt)
JP (1) JP7556031B2 (lt)
KR (1) KR20220108123A (lt)
CN (1) CN114901282B (lt)
AU (1) AU2020398082A1 (lt)
BR (1) BR112022010493A2 (lt)
CA (1) CA3162952C (lt)
DK (1) DK4069232T3 (lt)
ES (1) ES3059972T3 (lt)
FI (1) FI4069232T3 (lt)
IL (1) IL293416A (lt)
LT (1) LT4069232T (lt)
MA (1) MA57829B1 (lt)
MX (1) MX2022006535A (lt)
PL (1) PL4069232T3 (lt)
PT (1) PT4069232T (lt)
RS (1) RS67679B1 (lt)
SM (1) SMT202600019T1 (lt)
WO (1) WO2021111330A1 (lt)
ZA (1) ZA202206042B (lt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581492B1 (en) 2002-11-28 2008-07-16 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
AU2012271068A1 (en) * 2011-06-03 2013-12-19 Transition Therapeutics Ireland Limited Scyllo-inositol for the treatment of behavioral and psychiatric disorders
HRP20171245T1 (hr) 2013-12-02 2017-10-20 Suven Life Sciences Limited Postupak za proizvodnju velikih razmjera monohidrata 1-[(2-bromofenil)sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil)metil]-1h-indol dimezilata
NZ748280A (en) * 2016-05-18 2020-07-31 Suven Life Sciences Ltd Combination of pure 5-ht6 receptor antagonists with acetylcholinesterase inhibitors
MX384146B (es) 2016-05-18 2025-03-14 Suven Life Sciences Ltd Triple combinación de antagonistas del receptor de 5-ht6 puro, inhibidores de acetilcolinesterasa y antagonista del receptor de nmda.
HRP20210640T1 (hr) * 2016-05-18 2021-06-25 Suven Life Sciences Limited Kombinacija čistih 5-ht6 antagonista receptora sa nmda antagonistom receptora
SG11201913104QA (en) * 2017-07-03 2020-01-30 Suven Life Sciences Ltd New uses of a pure 5-ht 6 receptor antagonist

Also Published As

Publication number Publication date
DK4069232T3 (da) 2026-01-26
CA3162952C (en) 2024-06-11
KR20220108123A (ko) 2022-08-02
AU2020398082A8 (en) 2022-07-28
US20220409614A1 (en) 2022-12-29
JP7556031B2 (ja) 2024-09-25
EP4069232B1 (en) 2025-12-24
WO2021111330A1 (en) 2021-06-10
PT4069232T (pt) 2026-01-26
CA3162952A1 (en) 2021-06-10
CN114901282B (zh) 2024-06-25
CN114901282A (zh) 2022-08-12
IL293416A (en) 2022-07-01
MA57829B1 (fr) 2026-02-27
ES3059972T3 (en) 2026-03-24
EP4069232A1 (en) 2022-10-12
FI4069232T3 (fi) 2026-02-10
ZA202206042B (en) 2024-09-25
MX2022006535A (es) 2022-09-09
BR112022010493A2 (pt) 2022-09-06
AU2020398082A1 (en) 2022-06-16
JP2023506724A (ja) 2023-02-20
SMT202600019T1 (it) 2026-03-09
PL4069232T3 (pl) 2026-03-16
RS67679B1 (sr) 2026-02-27

Similar Documents

Publication Publication Date Title
IL285649A (en) Azepino-indoles and other heterocyclics for the treatment of brain disorders
GB202101954D0 (en) Methods and devices for reducing myopia in children
PT3768118T (pt) Métodos para dispor uma película de vedação superior num tabuleiro de cartão
EP3801744A4 (en) METHOD AND DEVICE FOR TREATING SLEEP-RELATED RESPIRATORY DISORDERS
IL276247A (en) Methods and materials for the treatment of sleep apnea
LT3903795T (lt) Nervinio audinio vienetas ir tokio vieneto naudojimas implantuojant į žinduolio nervų sistemą
IL276358A (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF ADDICTION AND RELATED DISORDERS
SG11202107844UA (en) Methods for treating symptoms and disorders associated with lysosomal storage diseases
IL276639A (en) Materials and methods for the treatment of dysproliferative diseases
ES3059972T3 (en) Masupirdine for treating behavioral and psychological symptoms in dementia
IL282965A (en) Electronic devices and treatment methods using antipsychotic drugs in combination with digital therapies
GB2603060B (en) Unit verification method and device
GB2572055B (en) Chute and method
PT4069231T (pt) Combinações de masupirdina com donepezilo ou memantina para tratamento de sintomas comportamentais e psicológicos em pacientes com demência
SG10202005848TA (en) Method for automatically validating cots and device for implementing the method
GB2596685B (en) Integrated milling and production device and method
GB2591387B (en) Waste treatment apparatus and method
GB201807232D0 (en) Database and associated method
IL289331A (en) Medicinal substance and method
ZA202105162B (en) System and method for the verification of medication
HK40050297A (en) Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
HK40039970A (en) Method and device for treating sleep related breathing disorders
SG11202104661WA (en) Composition and method for aiding sleep
GB201701196D0 (en) Method and apparatus for use in appraising a well structure
GB201706486D0 (en) Waste treatment apparatus and method